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Myoblast Fusion
C. A. Charlton, W. A. Mohler,1 and H. M. Blau2
Department of Molecular Pharmacology, Stanford University School of Medicine,
Stanford, California 94305
Considerable evidence points to an involvement of neural cell adhesion molecule (NCAM) in myoblast fusion. Changes in
the level of NCAM expression, isoform specificity, and localization in muscle cells and tissues correspond to key
morphogenetic events during muscle differentiation and repair. Furthermore, anti-NCAM antibodies have been shown by
others to reduce the rate of myoblast fusion, whereas overexpression of NCAM cDNAs increases the rate of myoblast fusion
compared to controls. In this study we have used a novel fusion assay based on intracistronic complementation of lacZ, in
combination with fluorescent X-gal histochemistry and immunocytochemistry to assess levels of NCAM expression in
individual muscle cells. Our results indicate that a substantial proportion of newly fused myoblasts have NCAM expression
levels unchanged from the levels of the surrounding unfused population suggesting that increased expression of NCAM is
not required for wild-type myoblasts to fuse. Moreover, pure populations of primary myoblasts isolated from mice
homozygous null for NCAM and therefore lacking the molecule, when placed in differentiation medium, consistently fused
to form contractile myotubes with kinetics equivalent to wild-type primary myoblasts. We conclude that the increase in
expression of NCAM, although typically observed during myogenesis, is not essential to myoblast fusion to form
myotubes. © 2000 Academic Press
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Neural cell adhesion molecule (NCAM) is among the
most prevalent of cell adhesion molecules found in verte-
brates. It is expressed in a wide range of early embryonic
tissues at sites of induction, but later in development is
found predominantly in nervous tissue and in developing
muscle where it is thought to function in such processes as
axonal bundling, migration of neurons, myogenesis, muscle
innervation, and synaptogenesis (Balak et al., 1987; Baldwin
et al., 1996; Covault et al., 1986; Edelman, 1985; Levi et al.,
987; Thiery et al., 1982; Walsh and Doherty, 1997). NCAM
exists as three major polypeptides with more than 20
different isoforms, all generated from a single 70-kb gene
(Cunningham et al., 1987; Dickson et al., 1987; Doherty
nd Walsh, 1991; Goridis and Brunet, 1992; Moore et al.,
987; Rutishauser and Landmesser, 1991). Expression of
1 Current address: Laboratory of Molecular Biology, University of
Wisconsin, 1525 Linden Drive, Madison WI, 53706. Fax: (608)
262-4570. E-mail: wamohler@facstaff.wisc.edu.
2 To whom correspondence should be addressed. Fax: (650) 725-
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112CAM isoforms occurs in a highly tissue-specific and
evelopmentally regulated manner, suggesting that the
ifferent NCAM isoforms have distinct functions.
In muscle development, both the level of expression of
pecific NCAM isoforms and their location within the cell
ave been shown to change in a manner that suggests that
CAM-mediated adhesion may play a role in timing or
irecting key events of myogenesis, such as the myoblast
usion that accompanies muscle formation or regeneration
ollowing injury (Covault and Sanes, 1986; Covault et al.,
986; Daniloff et al., 1986; Fredette et al., 1993; Moore et
l., 1987; Tosney et al., 1986). Numerous reports have
mplicated NCAM in myoblast adhesion and fusion (Mc-
onald et al., 1995). NCAM expression markedly increases
n populations of differentiating myoblasts and the fusion-
ompetent myotubes resulting from myoblast fusion (Co-
ault et al., 1986; Moore et al., 1987). Increased adhesion
etween myoblasts accompanies their ability to fuse (Knud-
en and Horwitz, 1977). Fab fragments of antiserum against
CAM significantly inhibit adhesion and have also been
hown to reduce the rate of primary chick myoblast fusion
Knudsen et al., 1990). Similarly, mouse C2C12 myoblasts
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113NCAM and Myoblast Fusionoverexpressing human NCAM cDNAs exhibit increased
rates of fusion compared to controls, and a species-specific
monoclonal antibody to human NCAM eliminates this
increase, strongly suggesting that the rate of fusion is
directly influenced by the additional NCAM expressed
(Dickson et al., 1990; Peck and Walsh, 1993). In addition to
an overall increase in the level of NCAM expression during
myogenesis, an increase in specific isoforms of NCAM is
correlated with fusion; a 140-kDa transmembrane isoform
predominates in proliferating myoblasts and is progres-
sively replaced during fusion by a 125-kDa NCAM isoform
(Covault et al., 1986; Me`ge et al., 1992; Moore et al., 1987).
Removal of the 125-kDa NCAM isoform from the surface of
chick myoblasts inhibits adhesion and fusion while over-
expression in transgenic mice enhances fusion (Fazeli et al.,
1996; Knudsen et al., 1989).
Some reports, however, minimize the role of NCAM in
myoblast fusion. Cifuentes-Diaz et al. (1993) and Me`ge et
al. (1992) observed only slight inhibition of fusion in the
presence of anti-NCAM antibodies. Furthermore, reports of
the targeted mutation of the single mouse gene encoding
the different NCAM isoforms have not described gross
defects in muscular development or alterations in the
viability of mutant animals (Cremer et al., 1994; Moscoso
et al., 1998; Wood et al., 1998). These results have been
nterpreted to suggest either that NCAM is not essential to
yogenic fusion or that redundant proteins can substitute
or its function in vivo.
This paper describes two types of studies designed to
igorously test the hypothesis that NCAM expression is
ssential to myoblast fusion. Both employ variations of a
ensitive b-galactosidase complementation assay devel-
ped in our laboratory (Mohler and Blau, 1996; Charlton
t al., 1997). In these assays, myoblasts were infected
ith retroviruses encoding either the Dm or the Dv
mutant b-galactosidase (b-gal) peptide and cocultured
nder growth or differentiation conditions. The first
tudy used b-gal complementation visualized by a novel,
ighly sensitive fluorescent X-gal substrate in conjunc-
ion with immunohistochemical staining of NCAM to
onitor at the level of an individual cell whether an
increase in NCAM expression correlates with the onset
of fusion competence. Previous studies were only able to
address fusion and NCAM expression levels in popula-
tions of fusing myoblasts. The second type of study used
b-gal complementation in a sensitive, quantitative bio-
hemical assay of fusion in cultures of primary myoblasts
erived from NCAM-null mice compared to cultures
erived from wild-type mice. Since myoblasts in culture
re not under selective pressure to fuse, detection of
ubtle differences in timing or efficiency of myoblast
usion would be possible by this method. Our results
how clearly that although NCAM may be involved in
uscle formation, its role in myoblast fusion is notssential. b
Copyright © 2000 by Academic Press. All rightMATERIALS AND METHODS
Culture of Cells
C2F3 myoblasts, nontransformed, highly fusogenic derivatives
of C2C12 myoblasts (Rastinejad and Blau, 1993), were grown in
C2F3 growth medium consisting of 15% calf serum (CS) and 5%
fetal bovine serum (FBS) (HyClone) in Dulbecco’s modified Eagle’s
medium (DMEM) (Irvine Scientific).
Two breeding pairs of homozygous NCAM-null mice (Cremer et
al., 1994) were provided by J. Merlie of Washington University.
Primary myoblasts were dissociated as previously described (Rando
and Blau, 1994) from muscle tissue of three neonatal (approxi-
mately 1 week of age) littermates, the progeny of a mating of
homozygous NCAM-null adult mice. Cells were subsequently
passaged in primary myoblast growth medium consisting of 40%
Ham’s F10/40% DMEM/20% FBS plus 2.5 ng/ml bFGF (Promega)
on dishes coated with Type I collagen (Sigma; concentration 0.1%
in 0.1 N acetic acid overnight and then rinsed with sterile water).
The NCAM-null primary myoblasts isolated from neonates were
pooled for subsequent culture. Wild-type myoblasts were similarly
isolated from three neonatal C3H mice, pooled, and cultured on
collagen.
Infection of Populations of Myoblasts with
Complementing Mutants of b-Gal
Two populations of each myoblast type, C2F3, C3H wild-type, or
NCAM-null, were separately transduced with retroviral constructs
encoding nonfunctional complementing b-gal mutants, either Dm
or Dv as previously described (Mohler and Blau, 1996). When these
mutant peptides are expressed together in the same cell or come
together through cell fusion, they are able to form a functional
enzyme that can be visualized or quantified using different sub-
strates.
Fluorescent Histochemistry
Glass coverslips (No. 1 thickness) were sterilized by baking and
then coated with Type I collagen (Sigma; concentration 0.1% in 0.1
N acetic acid) at 4°C overnight. Coverslips were rinsed with sterile
water and placed in 35-mm culture wells.
C2F3 myoblasts, expressing individually either Dm or Dv mu-
tants of b-gal, were cultured separately under normal growth
onditions. At time zero, trypsinized cells were suspended either in
ifferentiation medium (DM) consisting of 5% horse serum (HS)
Hyclone) in DMEM or in C2F3 growth medium, mixed in equal
roportion (Dm cells and Dv cells), and plated at a density of 106 per
ell (5 3 105 cells of each complementing cell type) on collagen-
oated cover-slips. After a time in coculture, cells were fixed for 5
in at room temperature with freshly prepared 4% paraformalde-
yde (Polysciences) in PBS, rinsed twice and stored at 4°C in PBS
ntil staining was performed.
All steps of the three-layer immunolabeling procedure were
erformed at 4°C. Fixed cells were incubated in blocking buffer
PBS 1 10% HS) for 30 min. Antibodies were diluted in blocking
uffer. Each antibody incubation proceeded for 2 h. The rat mono-
lonal antibody MAB310 (Chemicon) against mouse NCAM was
iluted 1:1000. A biotinylated goat anti-rat antibody (Vector) was
iluted 1:250. Cy5-labeled streptavidin (Amersham) was diluted
:1000. Four 10-min washes were performed with 2 ml of blocking
uffer between labeling steps. After the final Cy5–streptavidin
s of reproduction in any form reserved.
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114 Charlton, Mohler, and Blauincubation, cells were rinsed twice with blocking buffer and twice
with PBS.
Fluorescent X-gal staining solution contained 25 mg/ml 5-bromo-
-chloro-3-indolyl-b-D-galactopyranoside (Fluka) and 100 mg/ml
Fast Red Violet LB (Sigma) and was filtered (0.45 mm) before being
added to cells. b-Gal was allowed to activate the substrate at 37°C
for 60 min. Each coverslip was then individually rinsed in 25 ml
PBS at room temperature with gentle rocking for 1 h. Finally,
coverslips and cells were mounted on glass slides in PBS and sealed
with nail polish.
Slides were analyzed using the Molecular Dynamics Multiprobe
2010 confocal microscope located at the Stanford University Cell
Sciences Imaging Facility. Fluorescent X-gal product was excited
with the 488-nm line of the Kr/Ar laser and detected using a 515-
to 545-nm bandpass FITC emission filter. Cy5 was excited with the
647-nm laser line and detected with a 660-nm long-pass emission
filter. A 200-mm pinhole was used to maximize the depth of field.
For scoring of cells, laser power and photomultiplier voltages were
set empirically to allow faint detection of background for each
fluorochrome. Fields were scanned simultaneously at both wave-
lengths, and both images were displayed side by side in pseudo-
color, with the scale selected to show significant brightness above
background. Cells were scored manually based upon the pseudo-
color scale as positive or negative for b-gal and high or low for
expression of NCAM. At least 50 fields were scanned for each slide
analyzed. For pictorial display, b-gal activity is shown in green and
CAM immunocytochemistry is in red.
Western Immunodetection of NCAM in Wild-Type
and NCAM-Null Muscle Cell Cultures
Protein was extracted from C3H wild-type or NCAM-null pri-
mary myoblasts grown either in growth medium for three days or
in DM for 3 or 5 days. Equal amounts of protein, determined by
Bradford assay, were run in lanes of an SDS–polyacrylamide gel and
transferred to PVDF membrane (Millipore). Immunodetection was
performed using rat monoclonal antibody against mouse NCAM
(MAB310, Chemicon; diluted 1:1000), an antibody that recognizes
all NCAM isoforms, followed by HRP-conjugated goat anti-rat
antibody (Sigma; diluted 1:5000) and ECL detection (Amersham).
Prior to harvesting, cultures were photographed using a Sony CCD
IRIS/RGB color video camera attached to an inverted microscope.
b-Galactosidase Complementation Assay for
Fusion of Primary Myoblasts
Populations of NCAM-lacking (2/2) and C3H wild-type (1/1)
myoblasts were separately transduced with retroviral constructs
encoding either v or m, nonfunctional complementing mutant
eptides of the b-gal enzyme (Mohler and Blau, 1996). Cells
xpressing one peptide were mixed at equal densities with cells of
he same type expressing the complementing mutant peptide in
M, plated at 1.5 3 104 total cells/well of 96-well microplates. DM
as replaced daily. At the indicated time points, cells were lysed
nd processed as described (Mohler and Blau, 1996) for chemilumi-
escent assay using the Galacton-Plus chemiluminescent detec-
ion kit (Tropix). Functional b-gal enzyme activity was measured
sing a MicroBeta 1450 luminometer (Wallac). Data are expressed
s the means of eight replicate wells 6 SD. Myoblast fusion is
rofoundly affected by cell density. Therefore, it was extremely
mportant to plate equivalent numbers of cells and to analyze them
Copyright © 2000 by Academic Press. All rightn the same experiment in order to compare cell types or culture
onditions using this assay.
RESULTS AND DISCUSSION
NCAM Expression at the Level of Individual
Fusing Myoblasts
Application of the b-gal complementation system to the
tudy of fusion in nascent myotubes has several advantages.
irst, the signal produced by complemented b-gal activity
provides a clear and rapid means of identifying the few
small multinucleate cells that arise during the brief time
span of the experiment and distinguish them from a vast
population of unfused myoblasts. Furthermore, as the sig-
nal is fusion dependent, it assures that any binucleate cells
being considered have arisen through fusion and not
through incomplete cytokinesis, a phenomenon often seen
even among nonfusing cell types in tissue culture. Second,
mixing of complementing myoblasts at the outset of the
experiment results in a defined starting point for analysis of
the time course of fusion events. As b-gal-positive cells can
only arise after the plating of a coculture (Mohler and Blau,
1996), multinucleate cells which may have formed sponta-
neously in the separate cultures before time zero do not
produce active b-gal. Therefore, experiments can be focused
entirely on those cells which have fused within a well
defined time period. Third, a fluorogenic stain for b-gal
llows simultaneous visualization of other molecules by
mmunofluorescence microscopy. This permits analysis of
ingle cells in terms of two or more parameters, employing
he sensitivity and quantitative tools available for epifluo-
escence microscopy. In these respects, the technique
hould be especially useful in studying properties of other
usogenic cell types such as trophoblasts, macrophages, and
yoblasts in a range of species as well as the dynamics of
ellular components, such as the cytoskeleton and various
rganelles, within newly formed syncytia.
In our study, the sensitive assay of complementation of
b-gal was used as an indicator of recently fused cells using
either a myoblast cell line, C2F3, or primary myoblasts
isolated directly from mice and purified in culture to
eliminate nonmyogenic cell types. First, the expression of
surface NCAM was correlated with the onset of fusion
competence at the level of the single cell. Complementing
C2F3 myoblasts were mixed and plated in coculture at
experimental time zero. Only b-gal-positive cells were
cored after fixation and staining. Therefore, any fusion
vents that were analyzed had to have occurred between
ime zero and the time of fixation. Nascent b-gal-positive
myotubes appeared in complementing cocultures after 22
and 34 h from the time of plating (Table 1), but at both
times they constituted a very small percentage of the total
number of cells per field of view (Fig. 1). Among these,
b-gal-positive cells that displayed surface levels of NCAM
that were similar to the majority of surrounding unfused
myoblasts, and significantly lower than the NCAM levels
s of reproduction in any form reserved.
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115NCAM and Myoblast Fusionseen on the cells expressing the highest levels in the
culture, were not exceptional, but instead were frequently
observed (Table 1), indicating that high-level NCAM ex-
pression was not a prerequisite for fusion.
We tested the hypothesis that growth factor concentra-
tion might alter the requirement for NCAM in myoblast
fusion. This was possible because C2F3 cells plated at high
density are capable of fusing even in high-serum growth
medium. b-Gal-positive/low-NCAM cells were found in
cocultures plated in either low-serum differentiation me-
dium or in high-serum growth medium (Table 1). While the
overall frequency of b-gal-positive myotubes was lower in
high-serum growth medium than in low-serum differentia-
tion medium, the relative number of b-gal-positive fused
cells that expressed a low level of surface NCAM was much
higher in growth medium (33%) than in differentiation
medium (9.5%). This result is consistent with NCAM
expression increasing upon differentiation of myoblasts;
however, it does not support the hypothesis that high
NCAM expression is necessary for fusion to occur. Indeed,
the value of 33% probably underestimates the actual num-
ber of low-NCAM myoblasts that have undergone fusion; a
binucleate cell, for example, formed by the fusion of one
low-NCAM myoblast and one high-NCAM myoblast is
likely to display a relatively high level of NCAM. Table 1
TABLE 1
Analysis at the Single Cell Level of NCAM Surface Expression in
Newly Forming Myotubes
Culture
b-Gal-
positive
high-NCAM
b-Gal-
positive
low-NCAM
% Low-
NCAM/total
b-gal-positive
Differentiation medium
(low serum)
22 h 113 5 4.2
22 h 10 0 0.0
34 h 66 7 9.6
34 h 42 10 19.2
Total 231 22 9.5
rowth medium
(high serum)
22 h 58 12 17.1
34 h 14 6 30.0
34 h 9 9 50.0
Total 81 27 33.0
ow or high serum
Total 317 51 13.9
Note. C2F3 myoblasts, expressing either the Dm or Dv mutant of
b-galactosidase were cocultured in either high-serum growth me-
dium (5% FBS/15% CS) or low-serum differentiation medium (5%
HS) for 22 or 34 h, fixed, and stained for b-galactosidase comple-
mentation (b-gal-positive), a measure of cell fusion and for level of
NCAM expression at the surface of the newly forming myotube.
Each score shown is for an individual coverslip culture.shows the numbers of b-gal-positive/low-NCAM and b-gal-
Copyright © 2000 by Academic Press. All rightpositive/high-NCAM cells found in representative cultures
under these two sets of culture conditions. Figure 1 shows
examples of such b-gal-positive/low-NCAM cells that con-
rast clearly with both b-gal-positive/high-NCAM and
b-gal-negative/high-NCAM cells in the surrounding cul-
ture. The results of these studies of NCAM expression
levels in single newly fused myotubes strongly suggest that
the increase of surface NCAM expression which occurs in
differentiating skeletal muscle cells is a process that is
concomitant with but not a prerequisite for fusion compe-
tence.
Our conclusion from analysis at the single cell level that
fusion does not depend on high levels of NCAM expression
assumes that an individual myotube, once fused, does not
rapidly reduce its level of surface NCAM. Such a decrease
would have to occur in less than 22 h between the fusion
event (some time after experimental time zero) and the
earliest time examined. A pulsatile NCAM expression
pattern at the single cell level, although never described for
myoblasts, is not inconsistent with the overall increase in
NCAM expression which has been reported during myogen-
esis (Moore et al., 1987). Furthermore, muscle fibers in vivo
ndergo loss and recovery of high NCAM expression after
nnervation and denervation, respectively (Covault et al.,
986; Hahn and Covault, 1992), illustrating that NCAM
an be regulated even after myogenesis is complete. How-
ver, the time scale of these changes is much longer than
hat delimited by the design of the experiment reported
ere. Additionally, immunofluorescence microscopy of cul-
ures maintained for 5 days in differentiation medium
howed most myoblasts had fused at this time but main-
ained NCAM expression at a high level on the cell surface
data not shown). This finding argues against the possibility
hat a rapid decrease in NCAM expression occurs after
yoblasts fuse.
Analysis of Fusion in Wild-Type and NCAM-Null
Myoblasts in Vitro
Targeted mutation of the NCAM gene in mice produced
no gross defects in skeletal muscle (Cremer et al., 1994);
however, compensatory expression of another adhesion
molecule could have occurred. In vitro there is no selective
pressure to express NCAM since fusion is not essential to
survival of cells in culture. In addition, more subtle changes
in the time course or efficiency of fusion might become
apparent in purified populations of primary NCAM-null
myoblasts. We isolated primary myoblasts from a neonatal
litter of offspring of breeding pairs of mice homozygous null
for a targeted deletion of the gene encoding all forms of
NCAM. Expression of NCAM in these cells was assessed by
Western immunoblotting (Fig. 2A). As expected, levels of
NCAM expression increased in cultures of wild-type myo-
blasts kept 3 and 5 days in differentiation medium. Wild-
type myoblasts not exposed to differentiation medium, but
kept 3 days in growth medium, had only a faint NCAM-
reactive band of a higher molecular weight, while differen-
s of reproduction in any form reserved.
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117NCAM and Myoblast Fusiontiated myotubes showed progressively more of the lower
molecular weight NCAM isoform characteristic of myo-
tubes. In cultures of NCAM-null myoblasts or fully differ-
entiated fused and contracting NCAM-null myotubes, no
expression of any NCAM isoform was detected (Figs. 2A
and 2B). Primary myoblasts from NCAM-null mice fused
with kinetics and efficiency equivalent to myoblasts of
wild-type cultures (Fig. 3). These observations, together
with the studies described above showing that fusion com-
petence is independent of increased NCAM expression at
FIG. 1. Correlation of b-gal activity with expression of NCAM at t
the same field of cells. The left-most column is an overlay of image
for b-gal activity in green (middle column) and anti-NCAM imm
myotube with high NCAM staining that is b-gal negative. In row
CAM cells, and several b-gal-negative/high-NCAM cells. In row 3
FIG. 2. Western analysis of NCAM expression in wild-type and
NCAM-null myoblasts and myotubes. (A) Cells isolated from mice
wild-type (lanes 1–3) or homozygous null (lanes 4–6) for the
NCAM gene were grown for 0 days (lanes 1 and 4), 3 days (lanes 2
and 5), or 5 days (lanes 3 and 6) in low-serum differentiation
medium. Amount of protein extracted from resulting cultures was
equalized by the Bradford assay and analyzed by Western immuno-
blotting with anti-NCAM antibody that recognizes all isoforms of
NCAM. (B) Five day cultures of wild-type (left) or NCAM-null
(right) differentiated and contracting myotubes were photographed
prior to harvesting for Western analysis (magnification, 1403).high NCAM cells. In row 4 there is one b-gal-positive/low-NCAM cell a
Copyright © 2000 by Academic Press. All righthe single cell level, demonstrate clearly that NCAM is not
ssential for myoblast fusion to occur.
Two questions therefore arise. First, why in myogenesis
hould there be an increase in NCAM expression which is
onserved across species? Second, what is the significance
f studies in which overexpression of NCAM enhances the
ate of fusion in cultured myoblasts and antibodies to
CAM decrease that rate? It is thought that NCAM may be
mportant both in the higher order organization of muscle
issue and in the formation of neuromuscular contacts
eading to synaptogenesis. In development, a high level of
CAM is transiently expressed in embryonic muscle and
hen lost in normal adult muscle except at neuromuscular
unctions. The expression of a highly polysialylated form of
CAM has been temporally and ultrastructurally corre-
ated with the separation of chick secondary muscle fibers
rom the primary fibers along which they form (Fredette et
l., 1993; Allan and Greer, 1998), and in neuromuscular
evelopment, the overall pattern of NCAM expression on
uscle fibers in vivo parallels their time course of innerva-
ngle cell level. All panels in each horizontal row of the figure show
the middle and right columns that show fluorescent X-gal staining
staining in red (right column). In horizontal row 1, there is one
re is one b-gal-positive/low-NCAM cell, two b-gal-positive/high-
e is one b-gal-positive/low-NCAM cell and several b-gal-negative/
FIG. 3. Kinetics of fusion in wild-type and NCAM-null myoblasts
in vitro. A chemiluminescent assay was used to measure fusion of
wild-type (1/1) or NCAM homozygous null (2/2) myoblasts.
Separate populations of each cell type were transduced with
retroviral vectors containing either the Dm or Dv nonfunctional
mutant of b-galactosidase. When cultured together for various
imes in DM, fusion of myoblasts was measured as functional
b-galactosidase activity in chemiluminescent assay. Each point is
the average of eight replicates 6 SD.he si
s in
uno
2 the
thernd several b-gal-negative/high-NCAM cells (magnification, 2003).
s of reproduction in any form reserved.
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118 Charlton, Mohler, and Blaution (Rieger et al., 1985; Sanes et al., 1986). Anti-NCAM
ntibodies have been reported to block the formation of
ontacts between neuron processes and myotubes in vitro
Rutishauser et al., 1983) and have been reported to block
einnervation of synaptic sites in frog muscle basal lamina
fter surgical denervation (Me`ge et al., 1990). Polysialylated
CAM has also been implicated in the branching and
undling patterns of axon outgrowth and in the innervation
f developing and regenerating chick muscle (Landmesser
t al., 1988, 1990). In agreement with this putative role in
uscle fiber innervation, NCAM, especially polysialylated
CAM expression, is also increased on young regenerating
bers of mice (Dubois et al., 1994). However, in NCAM-
ull mice, although endplates of neuromuscular junctions
ere reduced, no deficits in motor function or ability to
einnervate were reported suggesting that effects upon
hese developmental processes must be minor or compen-
ated for in vivo by other molecules. Thus, despite the
bundance of reports to the contrary, we conclude that an
ssential function for NCAM in any aspect of neuromuscu-
ar development has yet to be established.
The question that remains is whether NCAM has a role
ntrinsic to muscle development independent of innerva-
ion. Several studies suggest that it does. Overexpression of
CAM in cultured myoblasts has been shown to enhance
he rate of cell fusion in two studies (Dickson et al., 1990;
eck and Walsh, 1993). An alternative explanation of these
esults is that increased overall adhesiveness can increase
he rate of myoblast fusion. The finding that increased
CAM expression leads to the increased adhesiveness
etween myoblasts that accompanies the onset of fusion
ompetence supports this finding (Knudsen and Horwitz,
977). It should be noted that neither overexpression study
ncludes controls which would allow a conclusion that
dhesion mediated specifically by NCAM is important for
he effect. Thus, it is quite possible that any other ho-
ophilic adhesion molecule, even one not normally ex-
ressed by myoblasts, could enhance myoblast fusion when
xpressed at high levels. Taken together, the lack of a
onsistent correlation at the single cell level between
ncreased NCAM expression and the acquisition of fusion
ompetence, the apparently normal development and
rowth of muscle in the NCAM-null mouse, and the ability
f primary myoblasts from these NCAM homozygous null
ice to differentiate and fuse in culture in a manner
quivalent to wild-type myoblasts suggest that NCAM per
e is not a required component of adhesion leading to
yogenic fusion.
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